Complete List of All AI Companies Under $2 Billion Market Cap

Page 20 of 45

26. Absci Corporation (NASDAQ:ABSI)

Market Capitalization: $320.33 Million

Number of Hedge Fund Holders: 20

Absci Corporation (NASDAQ:ABSI) is a generative AI drug creation company that integrates AI with scalable wet lab technologies to develop biologics more efficiently. Its Integrated Drug Creation platform accelerates drug development by optimizing multiple characteristics critical for both development and therapeutic success. The company can screen billions of cells weekly, enabling it to go from AI-designed antibodies to wet lab-validated candidates in just six weeks.

Absci  (NASDAQ:ABSI) recently achieved a few milestones in healthcare AI as it received a $20 million investment from AMD to support Absci’s AI-driven drug discovery initiatives. In addition, the company also partnered with Owkin to combine their AI-driven platforms to accelerate the discovery and design of novel therapeutics. Absci’s generative AI Drug Creation platform and Owkin’s predictive AI target discovery technology will work together to address new targets in immuno-oncology and other areas like immunology and inflammation.

Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Absci  (NASDAQ:ABSI) with a $7.00 price target. The rating reflects the strategic partnership with AMD for better AI-driven antibody development and the promising progress of AbSci’s internal pipeline, with key upcoming data points. The target is based on projected revenues and a conservative growth outlook.

Page 20 of 45